Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (KCT0011569) titled 'The therapeutic efficacy of Rebamipide eye solution in dry eye patients' on Feb. 3.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Pusan National University Hospital
Condition:
Diseases of the eye and adnexa
Intervention:
Drug : Patients included in this study were categorized into two groups: the treatment group, using 2% Rebamipide, and the control group, using 0.15% Hyaluronic acid. Over a total treatment period of 8 weeks, we aimed to compare the d...